High ME1 Expression Is a Molecular Predictor of Post-Transplant Survival of Patients with Acute Myeloid Leukemia

SIMPLE SUMMARY: Acute myeloid leukemia (AML) is a blood cancer caused by genetic aberrations acquired by bone marrow progenitor cells, impeding healthy hematopoiesis. While AML is a heterogenous disease and variable parameters can impact AML prognosis, the options for treatments remain limited. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortiz Rojas, César Alexander, Costa-Neto, Abel, Pereira-Martins, Diego A., Le, Duy Minh, Sternadt, Dominique, Weinhäuser, Isabel, Huls, Gerwin, Schuringa, Jan Jacob, Magalhães Rego, Eduardo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818450/
https://www.ncbi.nlm.nih.gov/pubmed/36612292
http://dx.doi.org/10.3390/cancers15010296

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818450/
https://www.ncbi.nlm.nih.gov/pubmed/36612292
http://dx.doi.org/10.3390/cancers15010296

Ejemplares similares